NDC11 00597014030
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00597-0140-30 | 00597-0140 |
| 00597-140-30 | 00597-140 |
| 0597-0140-30 | 0597-0140 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tradjenta | LINAGLIPTIN | Boehringer Ingelheim Pharmaceuticals, Inc. | c797ea5c-cab7-494b-9044-27eba0cfe40f | 2025-03-21 | Warnings, Adverse reactions | 0597-0140-30 0597-0140 00597014030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.